Opinion|Videos|June 27, 2024
Background on Colorectal Cancer Screening and its Role in Patient Care
Arvind Dasari, MD, MS, outlines the evolution of colorectal cancer screening, addressing historical challenges, and the development of non-invasive screening techniques.
Advertisement
Episodes in this series
- Dr Dasari: Please describe the importance and a brief history of CRC screening
- What are some challenges traditionally associated with CRC screening?
- Do these challenges vary between academic and community settings?
- How have noninvasive screening methods and age recommendations evolved over time?
- Please briefly mention the variety of sources (stool, blood, tissue, etc.) and methods that have become available
Advertisement
Related to this article
The FDA approved adjuvant atezolizumab with chemotherapy for patients with resected stage III dMMR colon cancer based on results from the phase 3 ATOMIC trial.
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Atezolizumab/Chemo for Stage III dMMR Colon Cancer
2
Building out a Radiopharmaceuticals Program in Oncology Care
3
How Emory Became the First Adopter of the Liberty Endovascular Robotic System
4
Iberdomide Combination Doubles PFS vs SOC Therapy in R/R Multiple Myeloma
5